Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
08/2007
08/14/2007US7255861 Preparations for inducing immunotolerance and uses therefor
08/14/2007CA2390189C Methods and pharmaceutical compositions for preventing problem behaviors of companion animals
08/14/2007CA2370030C Sodium channel blocker compositions and the use thereof
08/14/2007CA2239624C Treatment of negative and cognitive symptoms of schizophrenia with glycine uptake antagonists
08/14/2007CA2223176C Novel kappa receptor selective opioid peptides
08/14/2007CA2213714C Phenyl-substituted alkenylcarboxylic acid guanidides, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
08/14/2007CA2173504C Composition for drug delivery comprising nicotine or a derivative thereof and starch microspheres and method for the manufacturing thereof
08/09/2007WO2007089715A2 Method for treatment of neuropathic pain
08/09/2007WO2007089626A2 Anabaseine derivatives, pharmaceutical compositions and methods of use thereof
08/09/2007WO2007089193A1 A process for preparing 2-hydroxy-3- [5- (morpholin-4-ylmethyl)pyridin-2-yl] lh-indole-5-carbonitrile as a free base or salts thereof
08/09/2007WO2007089191A1 New citrate salt of an indole derivative and its pharmaceutical use
08/09/2007WO2007089151A1 Use of tlr3 agonists for the treatment of neurodegenerative disorders
08/09/2007WO2007089031A1 Piperidine derivatives as tachykinin receptor antagonists
08/09/2007WO2007089018A1 Triazole derivative
08/09/2007WO2007088895A1 3-arylamino-1,2,4-triazole derivative
08/09/2007WO2007088712A1 Neuronal cell death inhibitor and screening method
08/09/2007WO2007088681A1 Ghrelin production promoter
08/09/2007WO2007088473A2 Treatment and prevention of depression with pain, depression secondary to pain, and of neuropathic pain
08/09/2007WO2007088462A1 Spirochromane antagonists of the h-3 receptor
08/09/2007WO2007088450A2 Chromane antagonist of the h-3 receptor
08/09/2007WO2007088401A1 Indazole derivatives for treatment of alzheimer's disease
08/09/2007WO2007088400A1 Identification of compounds suitable for treating ad
08/09/2007WO2007088399A1 Upregulation of adamts4 protease activity for the treatment of alzheimer's disease
08/09/2007WO2007088190A1 Benzo (f) isoindol-2-ylphenyl acetic acid derivatives as ep4 receptor agonists
08/09/2007WO2007088189A1 Benzoisoindole derivatives for the treatment of pain
08/09/2007WO2007088034A2 Tuberous sclerosis treatment
08/09/2007WO2007087673A1 Domain antibody construct
08/09/2007WO2007068412A3 A beta 1-42 specific monoclonal antibodies with therapeutic properties
08/09/2007WO2007047978A3 Modulation of neurogenesis by pde inhibition
08/09/2007WO2007021886A3 Truncated memapsin 2 for use for treating alzheimer's disease
08/09/2007WO2006112550A3 A THERAPEUTIC AGENT FOR Aβ RELATED DISORDERS
08/09/2007WO2006031606A3 Carboxamide spirolactam cgrp receptor antagonists
08/09/2007US20070185337 Process for the preparation of optically pure 4-hydroxy-2-oxo-1-pyrrolidine acetamide
08/09/2007US20070185174 Use of thiazole derivatives for preparing a medicament intended to protect the mitochondria
08/09/2007US20070185169 2-Mercapto-4,5-Diarylimidazole Derivatives and the use thereof as Cyclooxygenase Inhibitors
08/09/2007US20070185168 Piperidine derivatives
08/09/2007US20070185151 Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane NMDA, 5HT3 and neuronal nicotinic receptor antagonists
08/09/2007US20070185137 Therapy for disease caused by nicotinic receptors; cognition activatrors; central nervous system disorders
08/09/2007US20070185127 2-(Arylalkoxy)-1-phenylethylamine derivatives as nk1 antagonist and serotonin reuptake inhibitors
08/09/2007US20070185126 Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing Them
08/09/2007US20070185119 Therapeutic agents II
08/09/2007US20070185115 Novel ureido-and amido-pyrazolone derivatives
08/09/2007US20070185112 Piperidine/piperazine-type inhibitors of p38 kinase
08/09/2007US20070185079 Therapeutic agents I
08/09/2007US20070185072 Nitrogeneous polycyclic derivatives useful as chelators of metal ions and their applications
08/09/2007US20070185048 ATP-binding cassette transporter polypeptide which regulates metabolism of triglycerides; treatment of obesity and eating disorders
08/09/2007US20070184435 Methods of screening apoptosis modulating compounds, compounds identified by said methods and use of said compounds as therapeutic agents
08/09/2007US20070184151 Use of a polyamine-poor composition for the production of a medical human food
08/09/2007US20070184114 Formulation for topical non-invasive application in vivo
08/09/2007US20070184109 Compositions comprising triptans and nsaids
08/09/2007US20070184090 PUFA supplements
08/09/2007US20070181124 Method and apparatus for dispensing inhalator medicament
08/09/2007DE10066158B4 Verwendung eines transdermalen therapeutischen Systems zur Behandlung des Restless-Legs-Syndroms Use of a transdermal therapeutic system for the treatment of Restless Legs Syndrome
08/09/2007CA2641900A1 A new salt
08/09/2007CA2641345A1 Indazole derivatives for treatment of alzheimer's disease
08/09/2007CA2641331A1 Identification of compounds suitable for treating ad
08/09/2007CA2640955A1 Upregulation of adamts4 protease activity for the treatment of alzheimer's disease
08/09/2007CA2640661A1 Domain antibody construct
08/09/2007CA2640454A1 Compounds and methods for modulating protein trafficking
08/09/2007CA2640366A1 Method for treatment of neuropathic pain
08/09/2007CA2640277A1 Benzo (f) isoindol-2-ylphenyl acetic acid derivatives as ep4 receptor agonists
08/09/2007CA2640274A1 Benzoisoindole derivatives for the treatment of pain
08/09/2007CA2637545A1 Anabaseine derivatives, pharmaceutical compositions and methods of use thereof
08/09/2007CA2637255A1 40-o-(2-hydroxyethyl)-rapamycin for treating tuberous sclerosis disorders
08/09/2007CA2635531A1 Multicyclic amino acid derivatives and methods of their use
08/09/2007CA2634879A1 Pharmaceutical formulations of oxcarbazepine and methods for its preparation
08/08/2007EP1816138A1 Cyclosporine analogue mixtures and their use as immunomodulating agents
08/08/2007EP1816136A1 Gpr7-selective ligand and use thereof
08/08/2007EP1816127A1 Triazine derivatives for use as selective npy (y5) antagonists
08/08/2007EP1816122A2 3,4,5-substituted piperidines as therapeutic compounds
08/08/2007EP1815863A1 Use of TLR3 agonists for the treatment of neurodegenerative disorders
08/08/2007EP1815862A1 Isolated stromal cells for use in the tretment of diseases of the central nervous system
08/08/2007EP1815854A1 Treatment of dyskenesia
08/08/2007EP1815853A1 Therapeutic agent for drug dependence
08/08/2007EP1815850A1 Controlled release formulation of divalproic acid and its derivatives
08/08/2007EP1814917A2 Single domain camelide anti-amyloid beta antibodies and polypeptides comprising the same for the treatment and diagnosis of degenerative neural diseases such as alzheimer's disease
08/08/2007EP1814888A1 Azabenzoxazoles for the treatment of cns disorders
08/08/2007EP1814887A1 Azabenzoxazoles for the treatment of cns disorders
08/08/2007EP1814883A1 Bicyclic inhibitors or rho kinase
08/08/2007EP1814876A2 Heterocyclic dye compounds for in vivo imaging and diagnosis of alzheimer's disease
08/08/2007EP1814873A2 5-sulfonyl-1-piperidinyl substituted indole derivatives as 5-ht6 receptor antagonists for the treatment of cns disorders
08/08/2007EP1814864A1 Nitro indazole derivatives
08/08/2007EP1814863A1 Indazole sulphonamide derivatives
08/08/2007EP1814857A1 Isotopically marked quinoline derivatives as adenosin a3 receptor ligands
08/08/2007EP1814849A1 Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor
08/08/2007EP1814589A1 Drug combination comprising a selective serotonin reuptake inhibitor and a glucocorticoid receptor antagonist for the treatment of depression
08/08/2007EP1814558A2 Methods and compositions for reducing neurodegeneration in amyotrophic lateral sclerosis
08/08/2007EP1814537A2 Macrocyclic tertiary amine beta-secretase inhibitors for the treatment of alzheimer's disease
08/08/2007EP1814527A1 Bilayer tablet comprising telmisartan and amlodipine
08/08/2007EP1708994B1 Aryloxyalkylcarbamate-type derivatives, preparation method thereof and use of same in therapeutics
08/08/2007EP1678180B1 Substituted 2h-[1,2,4]triazolo 4,3-a pyrazines as gsk-3 inhibitors
08/08/2007EP1631285B1 Therapeutic agents useful for treating pain
08/08/2007EP1611121B1 Pyridazinone derivatives as cdk2-inhibitors
08/08/2007EP1441717B1 Combination of an atp-competitive inhibitor of bcr/abl kinase activity and a tyrphostin analog
08/08/2007EP1423124B1 Lyophilized formulation comprising olanzapine
08/08/2007EP1411917B1 Carbamate compounds for use in preventing or treating movement disorders
08/08/2007EP1392728B1 Vaccine for the prevention and treatment of alzheimer's and amyloid related diseases
08/08/2007EP1360169B1 Succinate salt of o-desmethyl-venlafaxine
08/08/2007EP1351950B1 Isoquinolinyl aroyl pyrrole compounds for the treatment of central nervous system disorders
08/08/2007EP1347979B1 Indole derivatives and their use as 5-ht2b and 5-ht2c receptor ligands
1 ... 767 768 769 770 771 772 773 774 775 776 777 778 779 780 781 782 783 784 785 786 787 ... 1833